Combined annotation‐dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer

E-ISSN： 1349-7006|109|2|453-461

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.2, 2018-02, pp. : 453-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA‐negative breast cancers

Cancer Science, Vol. 109, Iss. 1, 2018-01 ,pp. : 166-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of weekly nab‐paclitaxel combined with S‐1 in patients with human epidermal growth factor receptor type 2‐negative metastatic breast cancer

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 734-739

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human leukocyte antigen‐E alleles and expression in patients with serous ovarian cancer

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 522-528

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammary tissue microenvironment determines T cell‐dependent breast cancer‐associated inflammation

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 867-874

John Wiley & Sons Inc

Access to resources Recommend Favorite

Src/STAT3‐dependent heme oxygenase‐1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 1023-1032

John Wiley & Sons Inc

Access to resources Recommend Favorite